KP Tissue Inc. (TSE:KPT – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of C$12.30 and traded as low as C$11.25. KP Tissue shares last traded at C$11.34, with a volume of 9,092 shares.
Analyst Upgrades and Downgrades
Separately, TD lifted their target price on shares of KP Tissue from C$12.00 to C$14.00 and gave the company a “hold” rating in a report on Tuesday, July 14th. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of C$12.12.
View Our Latest Analysis on KP Tissue
KP Tissue Trading Down 2.1%
KP Tissue (TSE:KPT – Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported C$0.24 earnings per share (EPS) for the quarter. On average, research analysts anticipate that KP Tissue Inc. will post 0.4398964 EPS for the current fiscal year.
KP Tissue Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 15th will be paid a $0.21 dividend. The ex-dividend date is Tuesday, September 29th. This represents a $0.84 dividend on an annualized basis and a yield of 7.3%. KP Tissue’s payout ratio is currently 85.23%.
KP Tissue Company Profile
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
See Also
- Five stocks we like better than KP Tissue
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
